Oragenics

(NYSEMKT) OGEN

Current Price$0.61

Market Cap$2.66M

Since IPO (2003)-100%

5 Year-100%

1 Year-90%

1 Month-7%

Oragenics Financials at a Glance

Market Cap

$2.66M

Revenue (TTM)

$0.00

Net Income (TTM)

-$9.83M

EPS (TTM)

-$6.12

P/E Ratio

-0.10

Dividend

$0.00

Beta (Volatility)

0.95 (Low)

Dividend

$0.00

Beta (Volatility)

0.95 (Low)

Price

$0.61

Volume

19,242.18

Open

$0.58

Price

$0.61

Volume

19,242.18

Open

$0.58

Previous Close

$0.59

Daily Range

$0.58 - $0.61

52-Week Range

$0.50 - $9.60

Dividend

$0.00

Beta (Volatility)

0.95 (Low)

Price

$0.61

Volume

19,242.18

Open

$0.58

Previous Close

$0.59

Daily Range

$0.58 - $0.61

52-Week Range

$0.50 - $9.60

OGEN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oragenics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Janet Huffman

Website

www.oragenics.com

Headquarters

Tampa, FL 33634, US

OGEN Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-311%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

-10.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.66M

Shares Outstanding

4.51M

Volume

19.24K

Avg. Volume

133.47K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$9.36M

EBITDA

-$9.36M

Operating Cash Flow

-$9.25B

Capital Expenditure

-$3.00

Free Cash Flow

-$9.25B

Cash & ST Invst.

$8.40M

Total Debt

$227.35K

Oragenics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$2.66M

N/A

Market Cap/Employee

$885.83K

N/A

Employees

N/A

Net Income

-$2.20M

+0.7%

EBITDA

-$2.26M

-11.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$6.05M

+598.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$56.13K

-97.8%

Return on Assets

-1.31%

N/A

Return on Invested Capital

-1.29%

N/A

Free Cash Flow

-$2.20M

-4.2%

Operating Cash Flow

-$2.20M

-4.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ENSCEnsysce Biosciences, Inc.

ENSCEnsysce Biosciences, Inc.$0.30-1.03%

CNSPCNS Pharmaceuticals, Inc.

CNSPCNS Pharmaceuticals, Inc.$4.90-4.30%

TTNPTitan Pharmaceuticals, Inc.

TTNPTitan Pharmaceuticals, Inc.$2.34-11.36%

QLGNQualigen Therapeutics, Inc.

QLGNQualigen Therapeutics, Inc.$3.21+5.59%

XBIOXenetic Biosciences, Inc.

XBIOXenetic Biosciences, Inc.$3.03-1.73%

SNGXSoligenix, Inc.

SNGXSoligenix, Inc.$0.80-7.58%

KZIAKazia Therapeutics Limited

KZIAKazia Therapeutics Limited$12.56+3.25%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CZRCaesars Entertainment

CZRCaesars Entertainment$29.05+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.64-0.02%

ATPCAgape Atp

ATPCAgape Atp$6.02+1.11%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.38+0.01%

SIDUSidus Space

SIDUSidus Space$5.18-0.15%

IALTBlackrock ETF Trust - iShares Systematic Alternatives Active ETF

IALTBlackrock ETF Trust - iShares Systematic Alternatives Active ETF$28.24+0.00%

IUSBiShares Trust - iShares Core Universal Usd Bond ETF

IUSBiShares Trust - iShares Core Universal Usd Bond ETF$46.15+0.00%

Questions About OGEN

What is the current price of Oragenics?

Oragenics is trading at $0.61 per share.

What is the 52-week range for Oragenics?

Over the past 52 weeks, Oragenics has traded between $0.50 and $9.60.

How much debt does Oragenics have?

As of the most recent reporting period, Oragenics reported total debt of $56.13K.

How much cash does Oragenics have on hand?

Oragenics reported $6.11M in cash and cash equivalents in its most recent financial results.

What is Oragenics’s dividend yield?

Oragenics does not currently have a dividend yield.

Oragenics

Oragenics Financials at a Glance

OGEN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Oragenics

OGEN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Oragenics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About OGEN

What is the current price of Oragenics?

What is the 52-week range for Oragenics?

How much debt does Oragenics have?

How much cash does Oragenics have on hand?

What is Oragenics’s dividend yield?

Premium Investing Services